title: Endophthalmitis after intravitreal injections.
abstract: Endophthalmitis following intravitreal injection is an infrequent but serious clinical problem. Infectious endophthalmitis must be differentiated from noninfectious inflammation. Depending on the series, the risk of endophthalmitis is very low. The use of a standardized injection protocol can reduce the risk of infection.
authors: University of Miami Miller School of Medicine, Bascom Palmer Eye Institute at Naples, Naples, FL 34102, USA. sschwartz2@med.miami.edu
authors: Stephen G
authors: SG
authors: Schwartz
authors: Harry W
authors: HW
authors: Flynn
authors: Ingrid U
authors: IU
authors: Scott
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002985:Clinical Protocols; D003030:Coagulase / Q000378:metabolism; D003937:Diagnosis, Differential; D009877:Endophthalmitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007267:Injections / Q000009:adverse effects* / Q000592:standards; D013210:Staphylococcus / Q000201:enzymology / Q000302:isolation & purification / Q000502:physiology; D014221:Triamcinolone / Q000009:adverse effects; D014792:Visual Acuity; D014822:Vitreous Body / Q000382:microbiology / Q000473:pathology
chemical_list: D000900:Anti-Bacterial Agents; D003030:Coagulase; D014221:Triamcinolone